Terveystalo (TTALO) CMD 2024 summary

Strategic progress, direction, and market positioning

• Achieved turnaround from historic low profitability in 2023 to exceeding EBITDA targets ahead of schedule, now setting a new minimum of 12.5% for the year and aiming for 10% EPS growth annually with moderate leverage and attractive dividends.

• Shifted from a turnaround focus to a confident growth agenda, leveraging a balanced, less risky business portfolio across Healthcare Services, Portfolio Businesses, and Sweden, with clear improvement agendas and tailored growth and margin targets.

• Emphasizing data-driven integrated care, digitalization, and customer-centricity as core competitive advantages, with investments in digital tools, prevention, and specialty care.

• Positioned as a leader in a resilient, growing private healthcare market, supported by demographic trends, insurance uptake, and digital transformation.

• No plans for transformational M&A or new country entries; growth will be primarily organic, with selective, disciplined acquisitions to complement the portfolio.

Operational and business area priorities

• Healthcare Services targets above-market growth, 5% annual revenue increase, incremental margin improvement, and best-in-class customer and employee experience, focusing on scaling prevention, digital channels, and insurance partnerships.

• Portfolio Businesses aim to double EBITDA margins by 2029, focusing on high-margin consumer pay segments (dental, massage), digital solutions for public sector, and preparing for public market ramp-up post-2026.

• Swedish operations are undergoing a profit improvement program, targeting a return to and surpassing historical profitability by 2027, with a focus on mid-sized private clients to reduce volatility and plans for profitable growth and expansion.

• Digitalization is central, with the Ella EMR platform and AI-driven process automation expected to reduce process costs by up to 40% by 2030, delivering significant productivity gains, cost reductions, and improved care compliance.

• Medical priorities include integrated care, prevention, and specialty growth (orthopedics, sleep, mental health, obesity, gynecology), with outcome measurement and digital tools supporting both patient and professional engagement.

Financial outlook and capital allocation

• De-risked business model with balanced margin structure, reduced reliance on diagnostics, and strong cash flow supports continued investment in organic growth and selective M&A.

• Updated financial targets: average 10% annual EPS growth, leverage below 2.5x, and dividend payout of at least 80% of net results, all based on real, not adjusted, profits.

• Investment focus on digital and physical assets to drive productivity and growth, with flexibility in property ownership and disciplined capital allocation.

• Growth in Healthcare Services will increasingly be volume-driven, with pricing still able to outpace inflation.

• Dental business plans to double revenue and reach industry-leading profitability within five years, with growth in Portfolio Businesses expected to be backloaded and public sector opportunities materializing after 2026.